|
1
|
Copelan EA: Hematopoietic stem-cell
transplantation. N Engl J Med. 354:1813–1826. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kanakry CG, Fuchs EJ and Luznik L: Modern
approaches to HLA-haploidentical blood or marrow transplantation.
Nat Rev Clin Oncol. 13:1322016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Majhail NS, Brazauskas R, Rizzo JD,
Sobecks RM, Wang Z, Horowitz MM, Bolwell B, Wingard JR and Socie G:
Secondary solid cancers after allogeneic hematopoietic cell
transplantation using busulfan-cyclophosphamide conditioning.
Blood. 117:316–322. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Majhail NS: Old and new cancers after
hematopoietic-cell transplantation. Hematology Am Soc Hematol Educ
Program. 142–149. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ehrhardt MJ, Brazauskas R, He W, Rizzo JD
and Shaw BE: Survival of patients who develop solid tumors
following hematopoietic stem cell transplantation. Bone Marrow
Transplant. 51:83–88. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rizzo JD, Curtis RE, Socié G, Sobocinski
KA, Gilbert E, Landgren O, Travis LB, Travis WD, Flowers ME,
Friedman DL, et al: Solid cancers after allogeneic hematopoietic
cell transplantation. Blood. 113:1175–1183. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Inamoto Y, Shah NN, Savani BN, Shaw BE,
Abraham AA, Ahmed IA, Akpek G, Atsuta Y, Baker KS, Basak GW, et al:
Secondary solid cancer screening following hematopoietic cell
transplantation. Bone Marrow Transplant. 50:1013–1023. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen MH, Chang PM, Li WY, Hsiao LT, Hong
YC, Liu CY, Gau JP, Liu JH, Chen PM, Chiou TJ and Tzeng CH: High
incidence of oral squamous cell carcinoma independent of HPV
infection after allogeneic hematopoietic SCT in Taiwan. Bone Marrow
Transplant. 46:567–572. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Themeli M, Petrikkos L, Waterhouse M,
Bertz H, Lagadinou E, Zoumbos N, Finke J and Spyridonidis A:
Alloreactive microenvironment after human hematopoietic cell
transplantation induces genomic alterations in epithelium through
an ROS-mediated mechanism: In vivo and in vitro study and
implications to secondary neoplasia. Leukemia. 24:536–543. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang L, Yu J and Wei W: Advance in
targeted immunotherapy for graft-versus-host disease. Front
Immunol. 9:10872018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Santella RM: Approaches to DNA/RNA
Extraction and whole genome amplification. Cancer Epidemiol
Biomarkers Prev. 15:1585–1587. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Obata T, Nakamura M, Mizumoto Y, Matsumoto
T, Takakura M and Fujiwara H: Synchronous endometrioid
adenocarcinomas in the uterine cervix and corpus. J Obstet Gynaecol
Res. 42:1390–1394. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Adeyanju MA and Ilori AA: Multiple primary
tumors. Niger J Clin Pract. 20:1346–1349. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fukuda M, Nakatsuka T, Kusama K and
Sakashita H: Patient with multiple primary carcinomas including 4
separate oral cancers: Study of p53 mutations and their
implications for management. J Oral Maxillofac Surg. 64:1672–1679.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Warren S: Multiple primary malignant
tumors. A survey of the literature and a statistical study. Am J
cancer. 16:1358–1414. 1932.
|
|
16
|
Hosokawa S, Takahashi G, Okamura J, Imai
A, Mochizuki D, Takizawa Y, Yamatodani T, Misawa K and Mineta H:
Risk and prognostic factors for multiple primary carcinomas in
patients with head and neck cancer. Jpn J Clin Oncol. 48:124–129.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li YD, Ma X, Han YL and Peng LW: Clinical
features of multiple primary carcinomas of the oral cavity. Exp
Ther Med. 13:634–638. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Danylesko I and Shimoni A: Second
malignancies after hematopoietic stem cell transplantation. Curr
Treat Options Oncol. 19:92018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vajdic CM, Mayson E, Dodds AJ, O'Brien T,
Wilcox L, Nivison-Smith I, Le Marsney R, Daniels B and Ashton LJ;
CAST study investigators, : Second cancer risk and late mortality
in adult australians receiving allogeneic hematopoietic stem cell
transplantation: A population-based cohort study. Biol Blood Marrow
Transplant. 22:949–956. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rizzo JD, Curtis RE, Socie G, Sobocinski
KA, Gilbert E, Landgren O, Travis LB, Travis WD, Flowers ME,
Friedman DL, et al: Solid cancers after allogeneic hematopoietic
cell transplantation. Blood. 113:1175–1183. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Morton LM, Saber W, Baker KS, Barrett AJ,
Bhatia S, Engels EA, Gadalla SM, Kleiner DE, Pavletic S and Burns
LJ: National institutes of health hematopoietic cell
transplantation late effects initiative: The subsequent neoplasms
working group report. Biol Blood Marrow Transplant. 23:367–378.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Weng X, Xing Y and Cheng B: Multiple and
recurrent squamous cell carcinoma of the oral cavity after
graft-versus-host disease. J Oral Maxillofac Surg. 75:1899–1905.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Taskinen M, Ryhanen S and Vettenranta K:
Graft-versus-host disease in stem cell transplantation. Duodecim.
133:251–258. 2017.PubMed/NCBI
|
|
24
|
Chien SH, Liu CJ, Hong YC, Teng CJ, Hu YW,
Shen CC, Ku FC, Chen SC, Yeh CM, Chiou TJ, et al: Use of
azathioprine for graft-vs-host disease is the major risk for
development of secondary malignancies after haematopoietic stem
cell transplantation: A nationwide population-based study. Br J
Cancer. 112:177–184. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Curtis RE, Metayer C, Rizzo JD, Socié G,
Sobocinski KA, Flowers ME, Travis WD, Travis LB, Horowitz MM and
Deeg HJ: Impact of chronic GVHD therapy on the development of
squamous-cell cancers after hematopoietic stem-cell
transplantation: An international case-control study. Blood.
105:3802–3811. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chang HA, Armenian SH and Dellinger TH:
Secondary neoplasms of the female lower genital tract after
hematopoietic cell transplantation. J Natl Compr Canc Netw.
16:211–218. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shanis D, Anandi P, Grant C, Bachi A, Vyas
N, Merideth MA, Pophali PA, Koklanaris E, Ito S, Savani BN, et al:
Risks factors and timing of genital human papillomavirus (HPV)
infection in female stem cell transplant survivors: a longitudinal
study. Bone Marrow Transplant. 53:78–83. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kawanishi S, Ohnishi S, Ma N, Hiraku Y and
Murata M: Crosstalk between DNA damage and inflammation in the
multiple steps of carcinogenesis. Int J Mol Sci. 18:18082017.
View Article : Google Scholar
|
|
29
|
Akiyama M, Yamaoka M, Ohyama W, Yokoi K,
Ashizuka S, Aizawa D, Ikegami M, Suzuki H, Ozaki K, Ida H and Yuza
Y: Genetic profile and microsatellite instability in a case of
secondary esophageal squamous cell carcinoma 12 years after
allogeneic hematopoietic stem cell transplantation for aplastic
anemia. J Pediatr Hematol Oncol. 42:302–306. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cordani M, Pacchiana R, Butera G, D'Orazi
G, Scarpa A and Donadelli M: Mutant p53 proteins alter cancer cell
secretome and tumour microenvironment: Involvement in cancer
invasion and metastasis. Cancer Lett. 376:303–309. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guo G and Cui Y: New perspective on
targeting the tumor suppressor p53 pathway in the tumor
microenvironment to enhance the efficacy of immunotherapy. J
Immunother Cancer. 3:92015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lujambio A, Akkari L, Simon J, Grace D,
Tschaharganeh DF, Bolden JE, Zhao Z, Thapar V, Joyce JA,
Krizhanovsky V and Lowe SW: Non-cell-autonomous tumor suppression
by p53. Cell. 153:449–460. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Knudson AG: Antioncogenes and human
cancer. Proc Natl Acad Sci USA. 90:10914–10921. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jain K, Mohapatra T, Das P, Misra MC,
Gupta SD, Ghosh M, Kabra M, Bansal VK, Kumar S, Sreenivas V and
Garg PK: Sequential occurrence of preneoplastic lesions and
accumulation of loss of heterozygosity in patients with gallbladder
stones suggest causal association with gallbladder cancer. Ann
Surg. 260:1073–1080. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Huang MF, Chang YC, Liao PS, Huang TH,
Tsay CH and Chou MY: Loss of heterozygosity of p53 gene of oral
cancer detected by exfoliative cytology. Oral Oncol. 35:296–301.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yamasaki S, Tani R, Sakurai S, Toratani S
and Okamoto T: Oral squamous cell carcinoma of the tongue dorsum
with multiple cancer-associated mutations in the TP53 gene. Oral
Oncol. 109:1047742020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang XH, Ding L, Fu Y, Chen S, Zhang L,
Zhang XX, Huang XF, Lu ZY, Ni YH and Hu QG: p53-positive expression
in dysplastic surgical margins is a predictor of tumor recurrence
in patients with early oral squamous cell carcinoma. Cancer Manag
Res. 11:1465–1472. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gao J, Wang Y, Yang J, Zhang W, Meng K,
Sun Y, Li Y and He QY: RNF128 promotes invasion and metastasis via
the EGFR/MAPK/MMP-2 pathway in esophageal squamous cell carcinoma.
Cancers (Basel). 11:8402019. View Article : Google Scholar
|
|
39
|
Lin X, Wen G, Wang S, Lu H, Li C and Wang
X: Expression and role of EGFR, cyclin D1 and KRAS in
laryngocarcinoma tissues. Exp Ther Med. 17:782–790. 2019.PubMed/NCBI
|
|
40
|
Mukerji AN and Wolf A: Synchronous
esophageal and lung cancer. Thorac Surg Clin. 28:97–104. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Dai L, Yang HL, Yan WP, Liang Z, Xiong HC,
Kang XZ, Yang YB, Fu H, Fan MY and Chen KN: The equivalent efficacy
of multiple operations for multiple primary lung cancer and a
single operation for single primary lung cancer. J Thorac Dis.
8:855–861. 2016. View Article : Google Scholar : PubMed/NCBI
|
